Acted as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC

    News Read

Panmure Gordon was delighted to act as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC for the recommended cash acquisition by Neurocrine Biosciences for c.£48m.

Panmure Gordon’s team included: Freddy Crossley, Emma Earl, Rupert Dearden and Mark Rogers.

Freddy Crossley

Managing Director, Head of Healthcare

Emma Earl

Managing Director, Healthcare, Investment Banking

Rupert Dearden

Managing Director, Corporate Broking Services